The DOI matches its Crossref record; 31 of the 31 references it cites were found in a registry or an index.
Docetaxel-Resistance in Prostate Cancer: Evaluating Associated Phenotypic Changes and Potential for Resistance Transfer via Exosomes
Open accessAbstract
BACKGROUND: Hormone-refractory prostate cancer remains hindered by inevitable progression of resistance to first-line treatment with docetaxel. Recent studies suggest that phenotypic changes associated with cancer may be transferred from cell-to-cell via microvesicles/exosomes. Here we aimed to investigate phenotypic changes associated with docetaxel-resistance in order to help determine the complexity of this problem and to assess the relevance of secreted exosomes in prostate cancer. METHODOLOGY/PRINCIPAL FINDINGS: Docetaxel-resistant variants of DU145 and 22Rv1 were established and characterised in terms of cross-resistance, morphology, proliferation, motility, invasion, anoikis, colony formation, exosomes secretion their and functional relevance. Preliminary analysis of exosomes from relevant serum specimens was also performed. Acquired docetaxel-resistance conferred cross-resistance to doxorubicin and induced alterations in motility, invasion, proliferation and anchorage-independent growth. Exosomes expelled from DU145 and 22Rv1 docetaxel-resistant variants (DU145RD and 22Rv1RD) conferred docetaxel-resistance to DU145, 22Rv1 and LNCap cells, which may be partly due to exosomal MDR-1/P-gp transfer. Exosomes from prostate cancer patients' sera induced increased cell proliferation and invasion, compared to exosomes from age-matched controls. Furthermore, exosomes from sera of patients undergoing a course of docetaxel treatment compared to matched exosomes from the same patients prior to commencing docetaxel treatment, when applied to both DU145 and 22Rv1 cells, showed a correlation between cellular response to docetaxel and patients' response to treatment with docetaxel. CONCLUSIONS/SIGNIFICANCE: Our studies indicate the complex and multifaceted nature of docetaxel-resistance in prostate cancer. Furthermore, our in vitro observations and preliminary clinical studies indicate that exosomes may play an important role in prostate cancer, in cell-cell communication, and thus may offer potential as vehicles containing predictive biomarkers and new therapeutic targets.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Valadi, H., Ekström, K., Bossios, A., Sjöstrand, M., Lee, J. J., & Lötvall, J. O. (2007) · Nature Cell Biology · doi:10.1038/ncb1596 · Cited by 12,834
Skog, J., Würdinger, T., van Rijn, S., Meijer, D. H., Gainche, L., Curry, W. T., Carter, B. S., Krichevsky, A. M., & Breakefield, X. O. (2008) · Nature Cell Biology · doi:10.1038/ncb1800 · Cited by 5,001
Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes
Alvarez-Erviti, L., Seow, Y., Yin, H., Betts, C., Lakhal, S., & Wood, M. J. A. (2011) · Nature Biotechnology · doi:10.1038/nbt.1807 · Cited by 4,930 · cited 1×
“Many more recent examples of these observations have been reported and a recent opinion by Mittelbrunn and SanchezMadrid [27] further describes how this transfer of genetic information may occur, with the effects of exosomes on secondary cells potentially contributing to carcinogenesis and tumour growth; moulding the…”
BackgroundMembrane vesicles as conveyors of immune responses
Théry, C., Ostrowski, M., & Segura, E. (2009) · Nature Reviews Immunology · doi:10.1038/nri2567 · Cited by 3,882
Intercellular communication: diverse structures for exchange of genetic information
Mittelbrunn, M., & Sánchez-Madrid, F. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3335 · Cited by 661
Astrocytes and Glioblastoma cells release exosomes carrying mtDNA
Guescini, M., Genedani, S., Stocchi, V., & Agnati, L. F. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-009-0288-8 · Cited by 661
Dallas, N. A., Xia, L., Fan, F., Gray, M. J., Gaur, P., van Buren, G., Samuel, S., Kim, M. P., Lim, S. J., & Ellis, L. M. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2023 · Cited by 572
Cheng, G. Z., Chan, J., Wang, Q., Zhang, W., Sun, C. D., & Wang, L.-H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1479 · Cited by 546
Yang, A. D., Fan, F., Camp, E. R., van Buren, G., Liu, W., Somcio, R., Gray, M. J., Cheng, H., Hoff, P. M., & Ellis, L. M. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0038 · Cited by 526
Potential role of HER2‐overexpressing exosomes in countering trastuzumab‐based therapy
Ciravolo, V., Huber, V., Ghedini, G. C., Venturelli, E., Bianchi, F., Campiglio, M., Morelli, D., Villa, A., Mina, P. D., Menard, S., et al. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.22773 · Cited by 514
Isolation and Characterization of RNA-Containing Exosomes
Lässer, C., Eldh, M., & Lötvall, J. (2012) · Journal of Visualized Experiments · doi:10.3791/3037 · Cited by 509
Lee, T. H., D’Asti, E., Magnus, N., Al-Nedawi, K., Meehan, B., & Rak, J. (2011) · Seminars in Immunopathology · doi:10.1007/s00281-011-0250-3 · Cited by 494
Chromosomal Instability Confers Intrinsic Multidrug Resistance
Lee, A. J. X., Endesfelder, D., Rowan, A. J., Walther, A., Birkbak, N. J., Futreal, P. A., Downward, J., Szallasi, Z., Tomlinson, I. P. M., Howell, M., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-3604 · Cited by 475
Development and Characterization of Gemcitabine-Resistant Pancreatic Tumor Cells
Shah, A. N., Summy, J. M., Zhang, J., Park, S. I., Parikh, N. U., & Gallick, G. E. (2007) · Annals of Surgical Oncology · doi:10.1245/s10434-007-9583-5 · Cited by 433
Amphiregulin exosomes increase cancer cell invasion
Higginbotham, J. N., Demory Beckler, M., Gephart, J. D., Franklin, J. L., Bogatcheva, G., Kremers, G.-J., Piston, D. W., Ayers, G. D., McConnell, R. E., Tyska, M. J., et al. (2011) · Current Biology · doi:10.1016/j.cub.2011.03.043 · Cited by 360 · cited 1×
“Limited studies, to date, have demonstrated that exosomes expressing amphiregulin [24] and HSP90a [25] can increase cancer cell motility and migration.”
BackgroundTumor cell-derived exosomes: A message in a bottle
Kharaziha, P., Ceder, S., Li, Q., & Panaretakis, T. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.03.006 · Cited by 337
McCready, J., Sims, J. D., Chan, D., & Jay, D. G. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-294 · Cited by 297
Tamm-Horsfall protein and urinary exosome isolation
Fernández-Llama, P., Khositseth, S., Gonzales, P. A., Star, R. A., Pisitkun, T., & Knepper, M. A. (2010) · Kidney International · doi:10.1038/ki.2009.550 · Cited by 290
Characterisation and manipulation of docetaxel resistant prostate cancer cell lines
O'Neill, A. J., Prencipe, M., Dowling, C., Fan, Y., Mulrane, L., Gallagher, W. M., O'Connor, D., O'Connor, R., Devery, A., Corcoran, C., et al. (2011) · Molecular Cancer · doi:10.1186/1476-4598-10-126 · Cited by 229
Self-citationCalzolari, A., Raggi, C., Deaglio, S., Sposi, N. M., Stafsnes, M., Fecchi, K., Parolini, I., Malavasi, F., Peschle, C., Sargiacomo, M., et al. (2006) · Journal of Cell Science · doi:10.1242/jcs.03228 · Cited by 190
Takeda, M., Mizokami, A., Mamiya, K., Li, Y. Q., Zhang, J., Keller, E. T., & Namiki, M. (2007) · The Prostate · doi:10.1002/pros.20581 · Cited by 146
Gabai, V. L., Budagova, K. R., & Sherman, M. Y. (2005) · Oncogene · doi:10.1038/sj.onc.1208495 · Cited by 131
Yu, D., Liu, B., Jing, T., Sun, D., Price, J. E., Singletary, S. E., Ibrahim, N., Hortobágyi, G. N., & Hung, M. (1998) · Oncogene · doi:10.1038/sj.onc.1201729 · Cited by 127
Exosomes for cancer immunotherapy
André, F., Escudier, B. J., Angevin, E., Tursz, T., & Zitvogel, L. (2004) · Annals of Oncology · doi:10.1093/annonc/mdh918 · Cited by 114
Isolation of Exosomes for Subsequent mRNA, MicroRNA, and Protein Profiling
Rani, S., O’Brien, K., Kelleher, F. C., Corcoran, C., Germano, S., Radomski, M. W., Crown, J. P., & O’Driscoll, L. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-289-2_13 · Cited by 111
Self-citationGuo, B., Villeneuve, D. J., Hembruff, S. L., Kirwan, A. F., Blais, D. E., Bonin, M., & Parissenti, A. M. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000021046.29834.12 · Cited by 70
Galectin-3 expression alters adhesion, motility and invasion in a lung cell line (DLKP), in vitro.
O’Driscoll, L., Linehan, R., Liang, Y. H., Joyce, H., Oglesby, I. K., & CLYNES, M. M. (2002) · PubMed · Cited by 66
Self-citationCell cycle perturbation and acquired 5-fluorouracil chemoresistance.
Guo, X., Goessl, E., Jin, G., Collie-Duguid, E. S. R., Cassidy, J., Wang, W., & O’Brien, V. (2008) · PubMed · Cited by 65
Shibata, T., Kokubu, A., Miyamoto, M., Hosoda, F., Gotoh, M., Tsuta, K., Asamura, H., Matsuno, Y., Kondo, T., Imoto, I., et al. (2010) · Oncogene · doi:10.1038/onc.2010.217 · Cited by 58
ALIX/AIP1 Is Required for NP Incorporation into Mopeia Virus Z-Induced Virus-Like Particles
Shtanko, O., Watanabe, S., Jasenosky, L. D., Watanabe, T., & Kawaoka, Y. (2011) · Journal of Virology · doi:10.1128/jvi.01984-10 · Cited by 47
Zhang, F., Chen, A., Chen, J., Yu, T., & Guo, F. (2011) · PubMed · Cited by 27
Cited by
Mesenchymal Stem Cell-derived Extracellular Vesicles: Toward Cell-free Therapeutic Applications
Rani, S., Ryan, A. E., Griffin, M. D., & Ritter, T. (2015) · Molecular Therapy · doi:10.1038/mt.2015.44 · Cited by 1,227
Self-citationExosomes in cancer development, metastasis, and drug resistance: a comprehensive review
Azmi, A. S., Bao, B., & Sarkar, F. H. (2013) · Cancer and Metastasis Reviews · doi:10.1007/s10555-013-9441-9 · Cited by 1,167
Exosomes in tumor microenvironment influence cancer progression and metastasis
Kahlert, C., & Kalluri, R. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1020-6 · Cited by 872
Effect of exosomal miRNA on cancer biology and clinical applications
Sun, Z., Shi, K., Yang, S., Liu, J., Zhou, Q., Wang, G., Song, J., Li, Z., Zhang, Z., & Yuan, W. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0897-7 · Cited by 800
Exosomes in cancer: small particle, big player
Zhang, X., Yuan, X., Shi, H., Wu, L., Qian, H., & Xu, W. (2015) · Journal of Hematology & Oncology · doi:10.1186/s13045-015-0181-x · Cited by 780
Metadata
- Authors
- Corcoran, C., Rani, S., O’Brien, K., O’Neill, A., Prencipe, M., Sheikh, R., Webb, G., McDermott, R., Watson, W., Crown, J., & O’Driscoll, L.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-12-10
- Volume
- 7
- Issue
- 12
- Pages
- e50999
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W1972741145
- Cited by
- 448
- References
- 31
- FWCI
- 17.08
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.